Soligenix, Inc.
SNGXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $5.66M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.28$1.76
- Volume (live)
- -
- Avg. volume (3M)
- 206.14K
Soligenix (SNGX) Stock Price & Financial Analysis
Soligenix Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.35 - $0.36 |
|---|---|
| 52-Week High | $1.76 |
| 52-Week Low | $0.28 |
| Open | $0.36 |
| Volume (last close) | 216.88K |
| Average Volume (3M) | 206.14K |
| 50-Day MA | $0.37 |
|---|---|
| 200-Day MA | $0.74 |
| 1-Year Change | −78.48% |
| Market Cap | 5.66M |
|---|---|
| Shares Outstanding | 15.95M |
| Price to Book (P/B) | 0.85 |
| EV/EBITDA | 0.33 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Soligenix at a Glance
As of the Oct 16, 2026 close, Soligenix (SNGX) has a market capitalization of $5.66M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $9.81M in cash and securities against $302.59K of debt, a net cash position of $9.51M.
Soligenix does not currently pay a dividend.
The share price is down 78.5% over the past year. At $0.35 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.28 to $1.76, below its 200-day moving average of $0.74.
Frequently Asked Questions About Soligenix
What is the current stock price for SNGX?
As of the Oct 16, 2026 close, SNGX stock trades at $0.35. The 52-week range is $0.28–$1.76, with a day range of $0.35–$0.36.
What is the P/E ratio for SNGX?
The P/E ratio (Price-to-Earnings) for SNGX is shown in the Key Statistics section. This valuation metric helps compare Soligenix, Inc. to industry peers.
Does SNGX pay dividends?
Soligenix does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SNGX?
Analyst ratings and recommendations for SNGX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SNGX?
As of the Oct 16, 2026 close, Soligenix's market capitalization is $5.6M, classifying it as a micro-cap company. Soligenix operates in the Healthcare sector within the Biotechnology industry.